We are live on ! Find out more
VKTXW

Viking Therapeutics, Inc.
VKTXW

Delisted

VKTXW was delisted on the 8th of April, 2021.

Back to rankings

3 hedge funds and large institutions have $497K invested in Viking Therapeutics, Inc. in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% less funds holding

Funds holding: 4 → 3 (-1)

25% less capital invested

Capital invested by funds: $665K → $497K (-$168K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
WAM
Warberg Asset Management
Illinois
-$219K
2
UBS Group
UBS Group
Switzerland
-$8.74K
Name Holding Trade Value Shares
Change 		Change in
Stake
PWAM
1
Park West Asset Management
California
$449K – – –
Morgan Stanley
2
Morgan Stanley
New York
$46K – – –
UBS Group
3
UBS Group
Switzerland
$2K -$8.74K -1,523 -80%
WAM
4
Warberg Asset Management
Illinois
– -$219K -163,536 Closed

VKTXW Hedge Fund Activity: Q1 2021 in Review

3 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics, Inc. (VKTXW) for Q1 2021, worth a combined $497K — down 25% from $665K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of VKTXW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest seller was Warberg Asset Management, exiting entirely with an estimated $219K sold.

  • 3 institutional investors held Viking Therapeutics, Inc. (VKTXW) as of Q1 2021, down from 4 in Q4 2020.
  • Funds reported $497K of Viking Therapeutics, Inc. stock for Q1 2021, down 25% quarter-over-quarter.
  • 0 funds opened new Viking Therapeutics, Inc. positions in Q1 2021 and 1 closed out, a net change of -1 holder.
  • The largest Viking Therapeutics, Inc. seller in Q1 2021 was Warberg Asset Management, an estimated $219K sold.

Based on aggregated 13F filings for Q1 2021.